Shirley Andrade Santos , Fernando Souza Nani , Elaine Imaeda de Moura , Diogo Lima de Carvalho , Guilherme Jorge Mattos Miguel , Cristiane Maria Federicci Haddad , Joaquim Edson Vieira , Victor Bunduki , Mário Henrique Burlacchini de Carvalho , Rossana Pulcineli Vieira Francisco , Daniel Dante Cardeal , Hermann dos Santos Fernandes
{"title":"特布他林和阿托西班作为子宫肌膜膨出宫内修复术中溶血剂的比较：一项回顾性队列研究。","authors":"Shirley Andrade Santos , Fernando Souza Nani , Elaine Imaeda de Moura , Diogo Lima de Carvalho , Guilherme Jorge Mattos Miguel , Cristiane Maria Federicci Haddad , Joaquim Edson Vieira , Victor Bunduki , Mário Henrique Burlacchini de Carvalho , Rossana Pulcineli Vieira Francisco , Daniel Dante Cardeal , Hermann dos Santos Fernandes","doi":"10.1016/j.bjane.2024.844495","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Myelomeningocele (MMC) is a neural tube defect disease. Antenatal repair of fetal MMC is an alternative to postnatal repair. Many agents can be used as tocolytics during the in utero fetal repair such as β2-agonists and oxytocin receptor antagonists, with possible maternal and fetal repercussions. This study aims to compare maternal arterial blood gas analysis between terbutaline or atosiban, as tocolytic agents, during intrauterine MMC repair.</p></div><div><h3>Methods</h3><p>Retrospective cohort study. Patients were divided into two groups depending on the main tocolytic agent used during intrauterine MMC repair: atosiban (16) or terbutaline (9). Maternal arterial blood gas samples were analyzed on three moments: post induction (baseline, before the start of tocolysis), before extubation, and two hours after the end of the surgery.</p></div><div><h3>Results</h3><p>Twenty-five patients were included and assessed. Before extubation, the terbutaline group showed lower arterial pH (7.347 ± 0.05 vs. 7.396 ± 0.02 for atosiban, <em>p</em> = 0.006) and higher arterial lactate (28.33 ± 12.76 mg.dL<sup>−1</sup> vs. 13.06 ± 6.35 mg.dL<sup>−1</sup>, for atosiban, <em>p</em> = 0.001) levels.</p></div><div><h3>Conclusions</h3><p>Patients who received terbutaline had more acidosis and higher levels of lactate, compared to those who received atosiban, during intrauterine fetal MMC repair.</p></div>","PeriodicalId":32356,"journal":{"name":"Brazilian Journal of Anesthesiology","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0104001424000174/pdfft?md5=dbaa845b4aa6c764f06ad927577cbfab&pid=1-s2.0-S0104001424000174-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Comparison of terbutaline and atosiban as tocolytic agents in intrauterine repair of myelomeningocele: a retrospective cohort study\",\"authors\":\"Shirley Andrade Santos , Fernando Souza Nani , Elaine Imaeda de Moura , Diogo Lima de Carvalho , Guilherme Jorge Mattos Miguel , Cristiane Maria Federicci Haddad , Joaquim Edson Vieira , Victor Bunduki , Mário Henrique Burlacchini de Carvalho , Rossana Pulcineli Vieira Francisco , Daniel Dante Cardeal , Hermann dos Santos Fernandes\",\"doi\":\"10.1016/j.bjane.2024.844495\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Myelomeningocele (MMC) is a neural tube defect disease. Antenatal repair of fetal MMC is an alternative to postnatal repair. Many agents can be used as tocolytics during the in utero fetal repair such as β2-agonists and oxytocin receptor antagonists, with possible maternal and fetal repercussions. This study aims to compare maternal arterial blood gas analysis between terbutaline or atosiban, as tocolytic agents, during intrauterine MMC repair.</p></div><div><h3>Methods</h3><p>Retrospective cohort study. Patients were divided into two groups depending on the main tocolytic agent used during intrauterine MMC repair: atosiban (16) or terbutaline (9). Maternal arterial blood gas samples were analyzed on three moments: post induction (baseline, before the start of tocolysis), before extubation, and two hours after the end of the surgery.</p></div><div><h3>Results</h3><p>Twenty-five patients were included and assessed. Before extubation, the terbutaline group showed lower arterial pH (7.347 ± 0.05 vs. 7.396 ± 0.02 for atosiban, <em>p</em> = 0.006) and higher arterial lactate (28.33 ± 12.76 mg.dL<sup>−1</sup> vs. 13.06 ± 6.35 mg.dL<sup>−1</sup>, for atosiban, <em>p</em> = 0.001) levels.</p></div><div><h3>Conclusions</h3><p>Patients who received terbutaline had more acidosis and higher levels of lactate, compared to those who received atosiban, during intrauterine fetal MMC repair.</p></div>\",\"PeriodicalId\":32356,\"journal\":{\"name\":\"Brazilian Journal of Anesthesiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-03-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0104001424000174/pdfft?md5=dbaa845b4aa6c764f06ad927577cbfab&pid=1-s2.0-S0104001424000174-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brazilian Journal of Anesthesiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0104001424000174\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brazilian Journal of Anesthesiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0104001424000174","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
Comparison of terbutaline and atosiban as tocolytic agents in intrauterine repair of myelomeningocele: a retrospective cohort study
Background
Myelomeningocele (MMC) is a neural tube defect disease. Antenatal repair of fetal MMC is an alternative to postnatal repair. Many agents can be used as tocolytics during the in utero fetal repair such as β2-agonists and oxytocin receptor antagonists, with possible maternal and fetal repercussions. This study aims to compare maternal arterial blood gas analysis between terbutaline or atosiban, as tocolytic agents, during intrauterine MMC repair.
Methods
Retrospective cohort study. Patients were divided into two groups depending on the main tocolytic agent used during intrauterine MMC repair: atosiban (16) or terbutaline (9). Maternal arterial blood gas samples were analyzed on three moments: post induction (baseline, before the start of tocolysis), before extubation, and two hours after the end of the surgery.
Results
Twenty-five patients were included and assessed. Before extubation, the terbutaline group showed lower arterial pH (7.347 ± 0.05 vs. 7.396 ± 0.02 for atosiban, p = 0.006) and higher arterial lactate (28.33 ± 12.76 mg.dL−1 vs. 13.06 ± 6.35 mg.dL−1, for atosiban, p = 0.001) levels.
Conclusions
Patients who received terbutaline had more acidosis and higher levels of lactate, compared to those who received atosiban, during intrauterine fetal MMC repair.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
